Drug Patent Expirations in January 2009

January 3, 2009

in General Biotechnology

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in January 2009

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
COVERA-HS Gd Searle Llc verapamil hydrochloride 5,082,668 Jan 21, 2009
GLYSET Pharmacia And Upjohn miglitol 4,639,436 Jan 27, 2009
KEPPRA Ucb Inc levetiracetam 4,943,639 Jan 14, 2009
KEPPRA XR Ucb Inc levetiracetam 4,943,639 Jan 14, 2009
LAMICTAL Glaxosmithkline lamotrigine 4,602,017 Jan 22, 2009
LAMICTAL CD Glaxosmithkline lamotrigine 4,602,017 Jan 22, 2009
MYLOTARG Wyeth Pharms Inc gemtuzumab ozogamicin 5,079,233 Jan 7, 2009
PRAVACHOL Bristol Myers Squibb pravastatin sodium 5,030,447 Jan 9, 2009
PRAVACHOL Bristol Myers Squibb pravastatin sodium 5,180,589 Jan 9, 2009
PRAVIGARD PAC (COPACKAGED) Bristol Myers Squibb aspirin; pravastatin sodium 5,030,447 Jan 9, 2009
PRAVIGARD PAC (COPACKAGED) Bristol Myers Squibb aspirin; pravastatin sodium 5,180,589 Jan 9, 2009
TRICOR Abbott fenofibrate 4,895,726 Jan 19, 2009
TRICOR (MICRONIZED) Abbott fenofibrate 4,895,726 Jan 19, 2009
XIBROM Ista Pharms bromfenac sodium 4,910,225 Jan 24, 2009
ZOLOFT Pfizer sertraline hydrochloride 5,744,501 Jan 6, 2009
ZOLOFT Pfizer sertraline hydrochloride 5,789,449 Jan 6, 2009

Courtesy of DrugPatentWatch.com

Want to receive this information by email? Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Share this page
[Facebook] [Google] [LinkedIn] [Twitter] [Email]

{ 1 comment… read it below or add one }

Generic Drug Buyer March 3, 2010 at 3:01 pm

Its always good to know when more brand name drugs finally turn generic. The cost saving can be amazing.

Leave a Comment

Previous post:

Next post: